TW200500060A - Composition and use of allylamine derivatives - Google Patents
Composition and use of allylamine derivativesInfo
- Publication number
- TW200500060A TW200500060A TW093107303A TW93107303A TW200500060A TW 200500060 A TW200500060 A TW 200500060A TW 093107303 A TW093107303 A TW 093107303A TW 93107303 A TW93107303 A TW 93107303A TW 200500060 A TW200500060 A TW 200500060A
- Authority
- TW
- Taiwan
- Prior art keywords
- allylamine derivatives
- composition
- inhibition
- allylamine
- derivatives
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/637,931 US20050032904A1 (en) | 2003-08-08 | 2003-08-08 | Composition and use of allylamine derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
TW200500060A true TW200500060A (en) | 2005-01-01 |
Family
ID=34116684
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW093107303A TW200500060A (en) | 2003-08-08 | 2004-03-18 | Composition and use of allylamine derivatives |
Country Status (3)
Country | Link |
---|---|
US (1) | US20050032904A1 (zh) |
CN (1) | CN1579379A (zh) |
TW (1) | TW200500060A (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100364520C (zh) * | 2006-04-24 | 2008-01-30 | 魏锐 | 盐酸特比萘芬栓剂及其制备方法 |
AU2012321107A1 (en) * | 2011-10-20 | 2013-05-16 | The Curators Of The University Of Missouri | Enzyme inhibitor for cancer treatment |
-
2003
- 2003-08-08 US US10/637,931 patent/US20050032904A1/en not_active Abandoned
-
2004
- 2004-03-18 TW TW093107303A patent/TW200500060A/zh unknown
- 2004-06-03 CN CNA2004100463071A patent/CN1579379A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
US20050032904A1 (en) | 2005-02-10 |
CN1579379A (zh) | 2005-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1079522A1 (en) | Thienyl compounds | |
HK1079519A1 (en) | Furyl compounds | |
MXPA03005893A (es) | Proteccion, restauracion, y mejora de celulas, tejidos y organos que responden a la eritropoyetina. | |
EP1478406A4 (en) | COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS AND OTHER MATERIALS AND METHOD FOR THE PRODUCTION AND USE THEREOF | |
IT1333697B (zh) | ||
SG150559A1 (en) | Antineoplastic combinations of cci-779 and rituximab | |
HK1080470A1 (en) | Heterocyclic compounds | |
PL1742644T3 (pl) | Kompozycja terapeutyczna zawierająca co najmniej jedną pochodną pirolobenzodiazepiny i fludarabiny | |
TW200621268A (en) | Antimicrobial copolymers and uses thereof | |
WO2004034990A3 (en) | Methods and compositions for use in treating cancer | |
IL173785A0 (en) | Anti-tumor formulations comprising defibrotide alone or in combination with other anti-tumor agents | |
EP1392328A4 (en) | ANTICANCER THERAPY | |
HK1057336A1 (en) | Pharmaceutical solutions of modafinil compounds | |
MXPA04001256A (es) | Productos de combinacion de derivados de propanolamina aril substituidos con otros ingredientes activos y su uso. | |
WO2004087098A3 (en) | Preserved ophthalmic compositions | |
HK1033910A1 (en) | Use of erythropoietin in the treatment of multiple myeloma | |
EP1383516A4 (en) | CO-ADMINISTRATION OF A POLYSACCHARIDE WITH A CHEMOTHERAPEUTIC AGENT FOR THE TREATMENT OF CANCER | |
MX2007011381A (es) | Composicion de espirulinas rica en principios activos, su proceso de obtencion y su utilizacion. | |
TW200500060A (en) | Composition and use of allylamine derivatives | |
HK1079116A1 (en) | Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy | |
MXPA05013121A (es) | Derivados de indol con efecto de induccion de apoptosis. | |
MXPA04005942A (es) | Composiciones y metodos de sintaxina 3. | |
MY141606A (en) | N-alkoxyalkyl-substituted benzimidazoles, their preparation and their use as agents against parasitic protozoa | |
MXPA03002494A (es) | Metodo para reducir toxicidad de quimio terapias combinadas. | |
GEP20115184B (en) | Pharmacokinetically improved compounds |